MedTrace Logo

Biobanking for Biomarkers In Respiratory Disease, Allergic Diseases and/or Mast Cell Disorders

NCT06037967 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3200

Last updated 2024-05-01

No results posted yet for this study

Summary

This study aims to build up a clinico-biological bank of samples from patients suspected of or suffering from allergic diseases (including asthma) or mast cell diseases in order to support future research in the field of allergic diseases. The biobank will help to identify new prognostic, diagnostic and/or predictive biomarkers.

Conditions

  • Allergic Diseases
  • Asthma
  • Mast Cell Disorders

Sponsors & Collaborators

  • University Hospital, Toulouse

    lead OTHER

Principal Investigators

  • Laurent GUILLEMINAULT, MD · University Hospital, Toulouse

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-02-28
Primary Completion
2038-05-31
Completion
2038-06-30

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06037967 on ClinicalTrials.gov